About Us

Building the future of
cardiovascular health

with smart imaging biomarkers

Mission

Build AI clinical decision-making solutions enabling a precise & personalized, understanding of patient’s cardiovascular risk.

Our History

IMAGEENS is a Paris-based healthtech founded in 2017, focused on the prevention & early diagnosis of cardiovascular diseases (CVD).

From its origin, IMAGEENS was plunged in international DeepTech and was created to build market-ready medical image processing software based on DeepTech technologies built over 10 years of technical and clinical research from world-class research institutions such as Sorbonne Université, the AP-HP, and Johns Hopkins.

Since its inception, IMAGEENS has demonstrated its ability to leverage advanced AI to build cutting-edge medical software. This innovation has been recognized through several prestigious French innovation competitions and multiple innovation labels.

Today, IMAGEENS is a spearhead company in the rapidly growing field of AI in cardiovascular health and medical imaging. IMAGEENS has the world’s most clinically validated technology to analyze arterial function by MRI, and is deploying this technology in combination with other AI components to revolutionize treatment decisions in cardiovascular health and beyond.

Highlights

2017

Imageens Founded

Labeled Jeune entreprise innovante (JEI)
Laureate ILAB – BPI France

2018

Technology transfer

Partenered with Sorbonne University and Gent University

2019

Development of first MVP

Selected to join the ParisTech incubator
Laureate Innov Up PIA Leader – BPI France
Laureates French Tech Seed – BPI France
Deeptech Award

2020

Fueling Cardiovascular Research with our Biomarkers

Partnership with UCL and Queen Mary University of London (UK)
Named Top-10 most influential e-health startups in France
Named Top-50 EU health tech startups
Named Top-10 Tech Transfer French startups (TechTour Future 21)
Laureates of the Next French Healthcare
Onwards to the EIT Health Catapult european semi-finals

2021

Structuring Healthcare Data with Label

Strategic Partnerhship with European’ largest medical data warehouse EDS/APHP
Selected to be part of the Sony Startup Acceleration Program Europe
selected to participate in EIT Health Amgen
Winners of the MICCAI Startup Village 2021

2022

First collaboration with Pharma company

Partenrship with Novartis to Leverage Label technology in managing large medical imaging databases
Got the ISO13485 certification
EIT health award

2023

First commercialization in clinical routine – Europe

Received the CE Class IIa MDR approval
Partnership with Prevention Clinic ICPC & Mieux
Partnership with one of the world’s best hospitals – Pitié salpétrière
First scientific paper showcasing the impact of our biomarker in aortic aneurysm

2024

Commercial Launch in North Africa

Partnership with Womia
Deployement in Tunisia with the agreement of ministry of health
First partnership with Insurance companies and corporates

2025

Commercial Launch in MENA region

Deployement in Dubai and Abu Dhabi

Awards

Partners

Regulatory informations

Imageens is recognized ISO 13485:2016 certifications from prestigious British Standards Institution (BSI) for medical device development. The company quality system is established and maintained to comply with European Medical Device Directive 93/42/EEC.